Lab
Lab Website: Epidemiology Research Group in Organ Transplantation
Selected Publications
Segev, DL, Gentry SE, Warren DS, Reeb B, Montgomery RA. Kidney Paired Donation and optimizing the use of live donor organs. JAMA. 2005 Apr 20; 293 (15) 1883-90.
Gentry SE, Segev DL, Montgomery RA. A comparison of populations served by Kidney Paired Donation and List Paired Donation. Am J Transplant. 2005 Aug; 5(8): 1914-21
Segev DL, Simpkins CE, Warren DS, King KE, Maley WR, Melancon JK, Cooper M, Kozlowski T, Montgomery RA. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J 2005 Oct;5(10):2570-75.
Segev DL, Gentry SE, Melancon JK, Montgomery RA. Characterization of waiting times in a simulation of kidney paired donation. Am J Transplant. 2005 Oct; 5(10):2448-55.
Montgomery RA, Zachary AA, Ratner LE, Segev DL, Hiller JM, Houp J, Cooper M, Kavoussi L, Jarrett T, Burdick J, Maley WR, Melancon JK, Kozlowski T, Simpkins CE, Phillips M, Desai A, Collins V, Reeb B, Kraus E, Rabb H, Leffell MS, Warren DS. Kidney Paired Donation permits successful transplantation with incompatible live kidney donors. JAMA. 2005 Oct 5;294(13):1655-63.
Montgomery RA, Gentry SE, Marks WH, Warren DS, Hiller J, Houp J, Zachary AA, Melancon JK, Maley WR, Rabb H, Simpkins CE, Segev DL. Domino paired kidney donation: a strategy to make best use of live non-directed donation. Lancet. 2006 Jul 29;368:419-21.
Simpkins CE, Montgomery RA, Hawxby AM, Gentry SE, Locke JE, Warren DS, Segev DL. The Effect of Cold Ischemic Time on Live Donor Renal Transplantation: Is Organ Transport Feasible for Live Donors? Am J Transplant. 2006.
Segev DL, Gentry SE, Montgomery RA. Association between waiting times for deceased donor kidney transplantation and rates of live donation. Am J Transplant. 2007 Oct;7(10):2406-13.
Gentry SE, Segev DL, Simmerling M, Montgomery RA. Expanding kidney paired donation through voluntary participation by compatible donors. Am J Transplant. 2007 Oct;7(10):2361-70.
Segev DL, Maley WR, Simpkins CE, Locke JE, Montgomery RA, Nguyen GC, Thuluvath P. Minimizing risk associated with elderly liver donors by matching to preferred recipients. Hepatology. 2007 Dec;46(6):1907-18.
Segev DL, Simpkins CE, Thompson RE, Locke JE, Warren DS, Montgomery RA. Obesity impacts access to kidney transplantation. J Am Soc Nephrology. 2008 Feb;19(2):349-55.
Segev DL, Kucirka LM, Nguyen GC, Cameron AM, Locke JE, Simpkins CE, Thuluvath PJ, Montgomery RA, Maley WR. Effect modification in liver allografts with prolonged cold ischemic time. Am J Transplant. 2008 Mar;8(3):658-66.
Segev DL, Sozio S, Shin EJ, Nazarian SM, Nathan H, Thuluvath PJ, Cameron AM, Montgomery RA, Maley WR. Steroid avoidance in liver transplantation: meta-analysis and meta-regression of randomized trials. Liver Transplantation. 2008 Apr;14(4):512-25.
Segev DL, Montgomery RA. Regional and Racial Disparities in the Use of Live Non-Directed Kidney Donors. Am J Transplant. 2008 May;8(5):1051-5.
Segev DL, Kucirka LM, Gentry SE, Montgomery RA. Current practice of kidney paired donation in the United States. Transplantation. 2008 Aug 27;86(4):502-10.
Montgomery RA, Katznelson S, Bry WI, Zachary AA, Houp J, Hiller JM, Shridharani S, John D, Singer AL, Segev DL. Successful three-way kidney paired donation with cross-country live donor organ transport. Am J Transplant. 2008 Oct;8(10):2163-8.
Segev DL, Thompson RE, Locke JE, Simpkins CE, Thuluvath PJ, Montgomery RA, Maley WR. Prolonged waiting times for liver transplantation in obese patients. Ann Surg. 2008 Nov;248(5):863-870.
Stewart ZA, Cameron AM, Signer AL, Dagher NN, Montgomery RA, Segev DL. Histidine-Tryptophan-Ketoglutarate (HTK) is associated with reduced graft survival in pancreas transplantation. Am J Transplant. 2009 Jan;9(1):217-221.
Locke JE, Montgomery RA, Warren DS, Segev DL. Renal transplantation in HIV-positive recipients: long-term outcomes and risk factors for graft loss. Arch Surg. 2009 Jan;144(1):83-86.
Stewart ZA, Cameron AM, Signer AL, Montgomery RA, Segev DL. Histidine-Tryptophan-Ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death. Am J Transplant. 2009 Feb;9(2):286-293.
Kucirka LM, Alexander C, Namuyinga R, Hanrahan C, Montgomery RA, Segev DL. Viral nucleic acid testing (NAT) and OPO-level disposition of CDC high-risk donor organs. Am J Transplant. 2009 Mar;9(3):620-8.
Kucirka LM, Namuyinga R, Hanrahan C, Montgomery RA, Segev DL. Formal policies and special informed consent are associated with higher provider utilization of CDC high-risk donor organs. Am J Transplant. 2009 Mar;9(3):629-35.
Lonze BE, Warren DS, Shah A, Stewart ZA, Dagher NN, Singer AL, Montgomery RA, Segev DL. Kidney transplantation in previous heart or lung recipients. Am J Transplant. 2008 Mar;9(3):578-85.
Segev DL, Kucirka LM, Oberai PC, Parekh RS, Boulware LE, Powe NR, Montgomery RA. Age and comorbidities are effect modifiers of gender disparities in renal transplantation. J Am Soc Nephrology. 2009 Mar;20(3):621-8.
Rees MA, Jopke JE, Pelletier RP, Segev DL, Rutter ME, Fabrega AJ, Rogers J, Pankewycz OG, Hiller J, Roth AE, Sandholm T, Unver U, Montgomery RA. A non-simultaneous extended altruistic donor chain. NEJM. 2009 Mar 12;360(11):1096-101.
Stewart ZA, Lonze BE, Warren DS, Signer AL, Dagher NN, Montgomery RA, Segev DL. Histidine-Tryptophan-Ketoglutarate (HTK) is associated with reduced graft survival of deceased donor kidney transplants. Am J Transplant. 2009 May;9(5):1048-54.
Kucirka LM, Namuyinga R, Hanrahan C, Montgomery RA, Segev DL. Provider utilization of high-risk donor organs and nucleic acid testing: results of two national surveys. Am J Transplant. 2009 May;9(5):1197-204.
Gentry SE, Montgomery RA, Swihart BJ, Segev DL. The roles of dominos and never-ending altruistic donor chains in kidney paired donation. Am J Transplant. 2009 Jun;9(6):1330-6.
Thuluvath PJ, Maheshwari A, Thuluvath NP, Nguyen GC, Segev DL. Survival after liver transplantation for hepatocellular carcinoma in MELD and pre-MELD eras and the independent impact of HCV. Liver Transplantation. 2009 Jun 26;15(7):754-762.
Massie AB, Zeger SL, Montgomery RA, Segev DL. The effects of DonorNet 2007 on kidney distribution equity and efficiency. Am J Transplant. 2009 Jul;9(7):1550-7.
Stewart ZA, Locke JE, Montgomery RA, Singer AL, Cameron AM, Segev DL. ABO-incompatible deceased donor liver transplantation in the United States: a national registry analysis. Liver Transplantation. 2009 Jul 29;15(8):883-93.
Melancon JK, Kucirka LM, Boulware LE, Powe NR, Locke JE, Montgomery RA, Segev DL. Impact of Medicare coverage on disparities in access to simultaneous pancreas and kidney transplantation. Am J Transplant. 2009 Dec;9(12):2785-91.
Segev DL, Muzaale AD, Caffo B, Mehta S, Taranto SE, McBride MA, Montgomery RA. Short-term and long-term survival in a 15-year cohort of all live kidney donors in the United States. JAMA. 2010 Mar 10;303(10):959-66.
Grams ME, Womer KL, Ugarte RM, Desai NM, Montgomery RA, Segev DL. Listing for expanded criteria donor kidneys in older adults and those with predicted benefit. Am J Transplant. 2010 Apr;10(4):802-9.
Kucirka LM, Ros RL, Subramanian AK, Montgomery RA, Segev DL. Provider response to a rare but highly publicized transmission of HIV through solid organ transplantation. Arch Surg. In press.
Kayler LK, Segev DL. The impact of nonidentical ABO deceased-donor kidney transplantation on kidney utilization. Am J Kidney Dis. In press.
Kucirka LM, Singer AL, Ros RL, Montgomery RA, Dagher NN, Segev DL. Underutilization of hepatitis C positive kidneys for hepatitis C positive recipients. Am J Transplant. In press.
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
Comments